Frederic Duchesne

Frederic Duchesne serves on the Board of Advisors at SOPHiA GENETICS and holds the position of Senior Advisor at ProductLife Group since March 2023. As a member of the Board of Directors at CEGEDIM and other organizations, including Cenexi and Quantum Genomics, Frederic has extensive experience in governance and strategic advisory roles. Frederic has also contributed as a Senior Advisor for Major Private Equity Firms and as a member of Angels Santé. Prior to these roles, Frederic was President & CEO of the Pharmaceuticals Division at Pierre Fabre and held significant positions at Bristol-Myers Squibb, including Vice President Europe and General Manager UK, and Vice President Hospital - Specialty Care France.